We present a novel microfluidic solid-phase extraction (µSPE) device for the affinity enrichment of biotinylated membrane proteins from whole cell lysates. The device offers features that address challenges currently associated with the extraction and purification of membrane proteins from whole cell lysates, including the ability to release the enriched membrane protein fraction from the extraction surface so that they are available for downstream processing. The extraction bed was fabricated in PMMA using hot embossing and was comprised of 3,600 micropillars.
Introduction
Membrane proteins play key roles in the pathology and physiology of biological cells, including regulating the trafficking of ions and solutes in/out of the cell, cell-to-cell interactions, and responses to stimuli through surface receptors.
1 Specific modifications to membrane proteins have been linked to different pathologic states such as cancer, neurological disorders, and diabetes. 2 Because of the interest in discovering and validating disease-specific protein signatures with diagnostic value or discovering new drug targets for personalized therapeutics, studies aimed at the identification, characterization, and quantification of membrane proteins has increased over the past few years. Most notably, several biopharmaceuticals that target membrane proteins are already being utilized for the treatment of tumors, lymphomas, and autoimmune diseases. 3 Membrane proteins represent approximately one-third of all proteins encoded by the human genome. 4 ,5 Yet, only a small fraction of the cell surface proteome has been characterized due to analytical challenges including: (i) Low abundance, especially compared to the cytosolic proteins; 1, 6 (ii) low frequency of tryptic cleavage sites in transmembrane domains; 7 (iii) the heterogeneity of membrane proteins; and (iv) their hydrophobicity making them prone to precipitation and aggregation and thus, sensitive to solubilization. 7, 8 A number of analytical approaches have been developed to aid in the analysis of membrane proteins for example ultracentrifugation, 9 ,10 affinity selection of modified or non-modified membrane proteins (antibody-or lectin-based approaches), 11, 12 two-phase partitioning 13, 14 and extraction. 15, 16 For example, detergent-based membrane protein recovery has been demonstrated to be as efficient as >90%; however, this efficiency was demonstrated for a mitochondrial membrane protein and recovery of a plasma membrane protein was only 50%. 17 Two important issues are apparent: (i) It is imperative to specifically isolate plasma membrane proteins as signal pathways must be stimulated by external interaction; 18 and (ii) the efficiency of detergent isolation intimately depends on the membrane protein's complexity and hydrophobicity, thereby imparting variability in extraction efficiency. 17 In general, the majority of detergent methods fail to produce highly pure isolates of membrane proteins due in large part to contamination from cytosolic proteins. 18 Alternatively, affinity-based isolation of membrane proteins avoids such variability and has the potential to target plasma membrane proteins specifically. Approaches utilizing antibodies for affinity isolation are challenged by the fact that the appropriate antibodies must be available for the necessary targets; one runs the risk of neglecting portions of the membrane proteome. 19 Recently, improved techniques for the enrichment of membrane proteins, both in vivo 20 and in vitro, 21 have been reported. These include the chemical capture of glycosylated membrane proteins, 22 silica beads with the appropriate membrane protein-specific coatings, 23, 24 or cell surface biotinylation followed by solid-phase affinity extraction using surface immobilized avidin. 20, 25, 26 Zhao et al. employed streptavidin-coated magnetic beads to enrich plasma membrane proteins that were obtained by lysing biotinylated cells from a human lung carcinoma cell line. The method resulted in a 400-fold enrichment of plasma membrane proteins relative to the endoplasmic reticulum, which was a major contaminant in the membrane fraction, dramatically reduced contamination from other cellular organelles, and as opposed to antibodybased methods, probed all portions of the membrane proteome accessible to surface labeling. 27 A variety of microfluidic sold-phase extraction devices (µSPE) have been developed that employ modification of microchannel solid surfaces with molecular reagents that bear the desired affinity agent, the use of polymeric membranes as sorbents, or the incorporation of magnetic or silica beads. 28, 29 The first demonstration of µSPE was performed by introducing silica beads into a microchannel for the analysis of amino acids and peptides. 29 Common to these µSPE devices, however, is the difficulty in handling whole cell lysates largely because impurities reduce the surface area available for specific isolation of the targets and cellular debris can cause clogging (i.e., device failure), especially when utilizing packed beads. [30] [31] [32] [33] We have previously demonstrated a simple and effective method for creating high surface area extraction beds that incorporate polymeric micropillars arrayed throughout a fluidic channel.
The devices were made from thermoplastics and could be molded from metal masters in a single step. [34] [35] [36] [37] This dramatically simplified device production by eliminating the need for loading silica beads into small channels or the formation of monoliths. However, to the best of our knowledge,
µSPE has yet to be applied for the analysis of membrane proteins from whole cell lysates. Our previous reports on using these µSPE devices were focused on analyzing nucleic acids. 34, 37 Herein, we present a µSPE device for the enrichment of membrane proteins by affinity selection from whole cell lysates. The µSPE device was fabricated by hot embossing into poly(methylmethacrylate), PMMA, and contained 3,600 micropillars within an extraction bed to provide high surface area. The extraction bed surfaces were covalently decorated with NeutrAvidin for selecting biotinylated membrane proteins from a cell lysate while minimizing background binding. [38] [39] [40] [41] [42] [43] Intact MCF-7 breast cancer cells were surface labeled with a membrane impermeable sulfo-NHS biotin reagent that ensured only membrane proteins were labelled and contained a disulfide linker that could later be cleaved by chemical reduction. The whole cell lysate was hydrodynamically passed through the µSPE device for extraction of the biotinylated membrane proteins, followed by release by cleaving the biotin moiety's disulfide linker with 1,4-dithiothreitol (DTT). The isolated protein fraction was evaluated for membrane protein recovery and potential cytosolic protein contamination by a sandwich assay and Western blotting, respectively, both of which indicated highly efficient and pure membrane protein recoveries. We highlight the importance of membrane protein solubility for successful extraction, the ability to release extracted proteins for downstream profiling, and provide avenues for enhanced device performance through computational simulations of micropillar geometry and spacing to guide future device designs.
Experimental

Reagents and chemicals
Materials used in these studies included PMMA substrates for the fabrication of the µSPE devices and 250 µm thick cover plates (Plaskolite, Columbus, OH); 177 µm ID polyetheretherketone for 20 min. The embossed device consisted of three independent channels (100 µm height, 24 mm long and 1.4 mm wide) each containing 3,600 micropillars (100 µm height, 100 µm diameter and 50 µm pillar-to-pillar spacing) that served as the µSPE bed. Each bed had a total surface area of 1.10 cm 2 .
NeutrAvidin immobilization
NeutrAvidin was immobilized to the walls and pillars of the µSPE device by covalent coupling to pendant carboxylic acid groups generated by UV/O 3 activation (as shown in Scheme 1 and outlined in Table S1 ). Briefly, NHS esters were formed by flooding the µSPE devices with EDC (6 mg mL -1 ) and NHS (60 mg mL -1 ) in 50 mM MES buffer (pH = 5.0) and incubating for 30 min at room temperature. The surface was rinsed with PBS then incubated with a 100 µL aliquot of NeutrAvidin (10 µM in PBS).
Cell biotinylation and lysis
MCF-7 cells were washed with ice-cold PBS three times and incubated for 5-10 min in 3 mL
TryplE express. Cells were centrifuged at 300x g for 10 min at 4ºC and resuspended at a concentration of 5 x 10 6 cells/mL in PBS. Eighty µL of sulfo-NHS-SS-biotin (10 mM, prepared immediately prior to use in nuclease-free H 2 O) was added to the cell suspension. Cells were incubated at room temperature for 30 min with constant mixing, centrifuged and resuspended in lysine (1 mg mL -1 in PBS) to quench the reaction, centrifuged and resuspended in ice-cold PBS and centrifuged to obtain a cell pellet. Cell lysis was performed by adding 50 µL of 4% CHAPS buffer (4% CHAPS, 7 M urea, 30 mM Tris-HCl, 2 M thiourea, and 5 mM magnesium acetate in 100 mL of nuclease-free H 2 O) to the pellet. Dialysis was performed using 7,00 MW cutoff 
Membrane protein extraction using the µSPE device
The steps employed in our µSPE device and assay of membrane proteins from whole cell lysates are shown in Scheme 1 and outline in Table S1 . The cell lysate (5 x 10 6 MCF-7 biotinylated cells per mL) was infused into the affinity bed at a volumetric flow rate of 5.0 µL/min so that biotinylated membrane proteins could be affinity selected by the surface-confined NeutrAvidin.
The surface was then rinsed with a high salt (1 M KCl) and high pH (0.1 M Na 2 CO 3 , pH = 11.5) wash to remove any loosely-bound cytosolic proteins. In some cases, we checked for the affinity selection of biotinylated membrane proteins by counter staining with a 100 µL solution consisting of FITC-avidin (50 µg/mL in PBS). 
Analyst Accepted Manuscript
Membrane protein extraction
Membrane proteins were extracted using a Mem-PER™ Plus Membrane Protein Extraction Reagent kit following the manufacturer's protocol. See the SI for details on this procedure.
Release of captured biotinylated membrane proteins from capture surface
After affinity selection of the biotinylated membrane proteins by the µSPE device, a 300 mM solution of DTT (in 4% CHAPS) was continuously infused into the SPE bed at a flow rate of 5.0 µL/min for 2 h to release the selected membrane proteins by reducing the disulfide bond carried in the sulfo-NHS-biotin reagent. Infusion was done in the dark to prevent photobleaching of FITC-avidin that was used to determine the efficiency of the release process. A total of 100 µL of PBS was then infused into the µSPE device and the chip was then imaged as outlined above. We further verified that the extracted proteins were indeed released from the affinity bed by 
Protein analysis by Western blotting
Gel runs for the blotting assay employed the BioRad Mini-PROTEAN System. The procedure is summarized here. Five mL of 3x Laemmli sample buffer (6% SDS, 30% glycerol, 187.5 mM Tris-HCl, 15% β-mercaptoethanol, 0.006% bromophenol blue) was added to each protein fraction to prepare them for gel electrophoresis. The fractions were heated at 95°C for 5 min, cooled on ice and briefly vortexed before being placed on the gel. The membrane was removed from the ECL solution and excess solution was carefully blotted away. The membrane was placed in a plastic sleeve and was exposed to film in a darkroom for 30 s and visualized. Figure S2 ). Due to computational limits, entire µSPE beds could not be simulated via COMSOL.
Computational fluid dynamics (CFD) simulations and diffusion analysis
The effects of protein diffusion throughout an entire bed's length were evaluated using an analytical solution to Fick's 2 nd law. The time-dependent position probability packet of a protein, initially centered between two pillars, was evaluated over a bed's length, L, according to its velocity (extracted from the CFD simulations), and the probability of immobilization was taken as the area of the Gaussian packet outside the fluidic channel's walls. We took into account pillar shape by applying a path correction factor, C, to the effective length traveled, where ‫ܮ‬ ൌ ‫ܥ‬ ‫ݔ‬ ‫.ܮ‬ For a circular pillar, protein travels about a half perimeter, yielding ‫ܥ‬ ൌ ߨ/2 ൎ 1.57, and for a diamond, the protein travels about a triangle, where there is a smaller effective length given 
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by C ൌ √2 ൎ 1.41. These path correction factors can be shown to be independent of pillar size or L. Details on this model's derivation and implementation are given in the SI.
Results and Discussion
The µSPE device utilized affinity selection for the specific isolation of membrane proteins from whole cell lysates. The affinity selection utilized NeutrAvidin molecules that were immobilized within the fabricated µSPE bed. Prior to cell lysis, the intact biological cells (MCF-7) were biotinylated. A disulfide moiety was incorporated into the biotinylation reagent so that membrane proteins could be released following affinity selection for downstream analysis (Scheme 1, Table   S1 ). The reducing agent cleaves the disulfide bond and as a result, releases the proteins with an attached residue of 104 g/mole per protein for each biotinylated site. In addition, it will reduce disulfides directly within proteins that contain such linkages. We will demonstrate both the efficiency of membrane protein extraction from whole cell lysates and the purity of the isolated fractions using this µSPE device compared to a detergent-based method. We will also present numerical simulations to guide future device designs for improved extraction efficiency and expanded dynamic range.
Solubilization, isolation, and release of biotinylated membrane proteins using the µSPE device
We first biotinylated membrane proteins found on MCF-7 cells using a membrane impermeable sulfo-NHS biotin reagent containing a disulfide linker. The success of biotinylation was confirmed by imaging whole cells labeled with fluorescent FITC-avidin (see Figure S1 ). Cells were then lysed with the whole cell lysate containing both cytosolic and biotinylated membrane proteins, which were subsequently passed through the µSPE bed that was decorated with
NeutrAvidin molecules (Scheme 1, Table S1 ). NeutrAvidin molecules were covalently anchored to the µSPE bed walls through the surface-confined carboxylic acids and accessible primary amine groups found on NeutrAvidin. Our group has shown that after UV/O 3 activation of PMMA, carboxylic acid functional groups are generated. 45 After removing potential cytosolic contaminants via a high salt and high pH wash, FITCavidin was introduced into the µSPE device, which bound to free biotin molecules found on the affinity selected proteins (2.7 biotin molecules per membrane protein) in a sandwich-type assay (Scheme 1, Table S1 , and Figure 2A ), which permitted direct observation of membrane proteins isolated in the µSPE bed. Note that control images (FITC-avidin incubated with the µSPE bed 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 without first passing through the cell lysate) indicated minimal nonspecific adsorption of the dyelabeled avidin ( Figure 2B ).
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The cell lysate/FITC-avidin sandwich indicated that the membrane proteins isolated in the µSPE device were aggregated (Figure 2A ) when introduced into the lysis buffer without CHAPS, likely due to poor solubilization of the membrane proteins. Solubilization of the membrane protein fraction is critical to the µSPE device's performance. If poorly solubilized, membrane proteins may appear as globular deposits on the surface of the µSPE bed as shown in Figure 2A .
Consequently, cytosolic contaminants could become trapped within the deposits as well as lipid contaminants. In addition, extraction may be enabled by mixed mechanisms including the specific biotin/avidin interaction and non-specific interactions (i.e., hydrophobic/hydrophobic). Under the operation of these non-specific interactions, the ability to release isolated membrane proteins by With increasing amounts of biotinylated membrane proteins infused through the µSPE bed, we observed decreased recovery. The recovery was found to be 88.9 ±2.4% when 0.02 pmol of biotinylated membrane proteins were processed. The µSPE data compared favorably to recoveries using the detergent-based technique, which recovered ~50% of the membrane proteins.
Also, recovery via the detergent-based technique is highly variable depending on the complexity and hydrophobicity of the membrane protein, 17 whereas the efficiency of the µSPE bed is dependent on the efficiency of biotinylation rather than hydrophobicity, permitting efficient sampling of nearly all membrane proteins. 27 When 10.7 pmol was processed, only 16.0 ±2.3% of protein was recovered, indicating that the µSPE bed was saturated with biotinylated membrane proteins ( Figure 3 ). From Figure 3 , the data suggested that the maximum amount of protein that could be loaded onto the µSPE bed was approximately 1.7 pmol. The theoretical load of immobilized NeutrAvidin, where NeutrAvidin is assumed to be a hard sphere with radii of 2.6 nm and is immobilized in a close packed hexagonal arrangement, 46 the maximum load of
NeutrAvidin was calculated to be 6.8 pmol. Assuming a 1:1 ratio between NeutrAvidin molecules and biotinylated membrane protein, the activated PMMA µSPE bed's maximum recovery when saturated by biotinylated membrane proteins was approximately 25% relative to theoretical
calculations. This observed difference may be attributed to inefficient UV/O 3 activation of the PMMA µSPE bed, which we have demonstrated previously. 47 Utilization of cyclic olefin copolymer (COC) as the fluidic substrate instead of PMMA should improve UV/O 3 activation efficiency, generating a higher and more uniform carboxylic acid surface density leading to higher loads of NeutrAvidin for more efficient recovery of biotinylated material and a larger dynamic range. 47 Furthermore, the device's dynamic range can be extended by fabricating µSPE beds with smaller and more densely packed pillars, which should increase the available surface area and also decrease diffusional distances.
37
Purity of membrane protein fractions obtained from the µSPE device and a bench-top detergent extraction method
We assessed the purity of the membrane proteins recovered from the µSPE device by Western blotting and staining for actin, a highly abundant cytosolic protein (~1 x 10 8 per cell) 48 and the epithelial cell adhesion molecule (EpCAM), which is a highly expressed membrane protein found in MCF-7 cells (>400,000 per cell 49 ). The presence of an actin band in the membrane protein fraction would indicate the presence of cytosolic impurities in the membrane protein fraction, while an EpCAM band in this same fraction would indicate successful isolation of membrane proteins. These results secured using the µSPE device were directly compared to a commercial, detergent-based extraction protocol.
Membrane and cytosolic protein fractions obtained by the detergent-based technique are shown in Figure 4 . The Western blot clearly showed the presence of actin with intense bands in the total cell lysate (T) and the cytosolic fraction (C). But, there was also the presence of actin in the membrane protein fraction (M), suggesting relatively high cytosolic contamination when attempting to isolate membrane proteins using the detergent-based technique. The same Western blot analysis was also performed after processing an MCF-7 whole cell lysate using the µSPE bed. In this case, no actin band was observed in the Western blots for the membrane protein fraction. We subsequently stained for EpCAM and confirmed the presence of this membrane protein in the fraction isolated via µSPE. Considering the abundance of actin relative to EpCAM, the absence of an actin band clearly indicated highly pure membrane protein fractions isolated using µSPE.
Computational modeling of micropillar geometry and membrane protein extraction
To further increase the device's dynamic range and the efficiency for recovering membrane proteins, we conducted computation modeling to guide future designs of the µSPE device.
Specifically, we were interested in investigating how micropillar geometry and spacing may affect the efficiency of membrane protein extraction. The simulations were carried out using computational fluid dynamics (CFD) with COMSOL Multiphysics and a numerical analysis using µm pillar-to-pillar spacing). The steady-state velocity fields (shown in Figure S2 ) were comparable in all geometries, which is not surprising given the low Reynolds number for these devices. Additionally, the velocities between the pillars were nearly uniform regardless of pillar position, indicating uniform protein distribution throughout all µSPE beds. Average linear velocities through the beds were extracted from the CFD simulations to assess diffusion occurring on the length scale of the entire µSPE bed, which would be numerically intractable to model using CFD simulations alone.
For cases with diffusion, a protein with its initial position centered between two pillars and described by a Gaussian probability packet that spreads over time according to its diffusion constant was propagated over a time scale proportional to its velocity and effective path length through the µSPE bed. The normalized area of the Gaussian packet outside the bounds of the fluidic pathways (overlapping with a micropillar itself) was taken as probable extraction onto a micropillar's surface. The results for several flow rates through geometries I-III are shown in Figure 5 . Two sets of results are shown; the first simulation less accurately assumes that the protein travels in a straight path through the bed (ignoring micropillars altogether), while the second uses an effective bed length corrected by a factor (C), which included the distance 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 required to circumnavigate a micropillar that was dependent on the micropillar's shape. Further details are provided in the SI.
As the flow rate increased, the probability of protein interaction with the pillar surface (P i ) decreased for all geometries. However, this dependency was less pronounced for Geometries II and III, which only had 20 µm pillar-to-pillar spacing and required less diffusion to occur for Lastly, inclusion of the path correction factor increased the time for diffusion and improved the probability of extraction and more so for circular pillars compared to diamond-shaped pillars, which have a larger perimeter ( ‫ܥ‬ ൌ ߨ/2 ൎ 1.57 ) than diamond pillars ( ‫ܥ‬ ൌ √2 ൎ 1.41 ).
However, this effect was minor when comparing Geometries II and III (an improvement of only 0.6% at 10 µL min -1 infusion) as the small pillar-to-pillar spacing induced higher recovery even when the path correction factor was ignored. Thus, future designs, especially those integrated with downstream protein separation and analysis, should employ µSPE beds with smaller, more densely packed pillars with smaller pillar-to-pillar spacing than that employed herein. This would also result in a higher surface area to improve recovery and the dynamic range.
Conclusion
A polymer microfluidic chip was designed, fabricated, and evaluated for the solid-phase extraction and purification of membrane proteins from whole cell lysates. The device contained 3,600 micropillars that provided a higher surface area for protein extraction compared to an open channel of the same dimensions, could be replicated from a mold master in a single step, and did not require complex post-processing steps for its operation, such as the addition of functionalized beads or the chemical formation of monolithic supports.
MCF-7 cells were biotinylated with a membrane impermeable reagent and then lysed. Whole cell lysates were processed through the µSPE device, where biotinylated membrane proteins were specifically selected using immobilized NeutrAvidin. Inclusion of a disulfide moiety within the biotinylation reagent framework permitted release of the extracted membrane proteins following reduction of the disulfide linkage. The µSPE assay produced significantly lower levels of cytosolic protein contamination compared to a commercially-available detergent method.
Furthermore, we were able to recover ~89% of biotinylated membrane proteins from a whole cell lysate. Thus, we demonstrated efficient recovery of highly pure fractions of membrane proteins that can be released for downstream analysis. The µSPE device comprised a simplified workflow to allow for the generation of information regarding a small but important portion of the proteome
that is typically difficult to analyze. 18, 51, 52 We also provided several avenues to increase both the recovery and dynamic range of the device including polymer choice and computational simulations indicating the benefits of small circular pillars with reduced pillar-to-pillar spacing.
The results secured using this µSPE device for the extraction and purification of membrane proteins will provide an attractive approach that can be integrated to other devices for future studies directed toward determining potential therapeutic targets or selection agents for various cell types due to the higher purity membrane protein fractions isolated and the ability to process small numbers of cells. For example, we have previously demonstrated microfluidic cell isolation units for isolating extremely rare, circulating tumor cells from whole blood patient samples with high purity. 53, 54 These microfluidic devices can be coupled to the µSPE device detailed in this manuscript to isolate plasma membrane proteins from these rare cells for downstream multidimensional electrophoresis for protein separation, 55, 56 solid-phase proteolytic digestion 57 and mass spectrometry for protein identification. [58] [59] [60] We are currently developing an integrated system incorporating these previously described devices with the µSPE device for top-down proteomic analysis of membrane proteins from rare cells, such as circulating tumor cells. 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 The total amount of protein (pmol) before and after µSPE purification was estimated from fluorescence data, which measured proteins that were biotinylated. Error bars in the graph represent standard deviations from three replicate runs. 6 MCF-7 cells were lysed and taken to a total volume of 1.0 mL. This lysate was either directly loaded onto the gel (30 µL) for Western analysis or diluted ~1000-fold with 100 µL processed using the µSPE device. Due to the limited bed capacity of the µSPE device, the EpCAM band intensity was much weaker for the µSPE device compared to direct processing of the lysate. Figure 5 . Illustration of the path correction factor (C) for both circular and diamond shaped micropillars. The probability of protein-post interaction (P i ) for Geometries I-III, both with (solid black or white, where ‫ܥ‬ ൌ ߨ/2 or √2) and without (solid grey, where ‫ܥ‬ ൌ 0) the path correction factor applied to the µSPE bed's length.
Scheme 1. Overview of the on-chip extraction/purification of biotinylated membrane proteins from cell lysates using the µSPE device. (A) Micropillar activation and NeutrAvidin immobilization; (B) whole cell lysate infusion where the biotinylated membrane proteins are affinity captured while contaminating cytosolic proteins are eluted; and (C) FITC-avidin addition used to label unreacted biotin of selected membrane proteins followed by disulfide bond reduction releasing either FITC-avidin labeled membrane proteins or unlabeled membrane proteins from the µSPE bed. Symbols are defined in the legend. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 Figure 1
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